Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
CederPharma AB
AB
Active
Org 5567771356
Norrtullsgatan 16 B, 113 45
Stockholm
Traditional, complementary and alternative medicine activities
·
NACE 8696
Est. 2009 · 17 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Traditional, complementary and alternative medicine activities
/
CederPharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
1M
1M
1M
0M
0M
2021: 0M
0M
2021
2022: 1M
1M
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
2025: 0M
0M
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
196
170
638
745
189
Staff expenses
−44
−69
−502
−282
—
EBITDA
29
11
−7
294
96
Depreciation & amort.
—
—
—
—
−0
EBIT
29
11
−7
294
96
Net financials
62
14
9
0
—
Profit before tax
62
25
1
311
79
Tax
−18
−6
−2
−64
−10
Net profit
44
20
−0
247
69
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
4 582
5 062
5 238
5 243
4 868
Equity
2 809
2 765
2 909
2 909
2 662
Long-term debt
1 710
—
—
—
2 161
Short-term debt
33
2 297
2 330
2 334
27
Total debt
1 743
2 297
2 330
2 334
2 188
Financial ratios
5-year trend
EBITDA margin
14.9%
This company
15.8%
Market median
This company
Market median
6% below market
2021
2025
Equity ratio
61.3%
This company
38.2%
Market median
This company
Market median
60% above market
2021
2025
Return on equity
1.6%
This company
18.4%
Market median
This company
Market median
91% below market
2021
2025
Net profit margin
22.5%
This company
8.1%
Market median
This company
Market median
178% above market
2021
2025
Asset turnover
0.04×
This company
1.12×
Market median
This company
Market median
96% below market
2021
2025
Debt / equity
0.63×
This company
0.62×
Market median
This company
Market median
2% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on CederPharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
